The post reports that healthcare stocks, including AbbVie, Eli Lilly, and Johnson & Johnson, are becoming a haven for investors fleeing tech, with shares on track for all-time highs.
MarketWatch06/27, 01:39 AM
Related assets
Coming up for ABBV
Explore next
Latest ABBV news
FirstSquawk08/20, 09:57 AM
Piper Sandler raised its price target on AbbVie to $303 from $298.
Bloomberg08/17, 06:28 PM
Bloomberg08/03, 04:58 PM